福元医药股价涨5.36%，易方达基金旗下1只基金位居十大流通股东，持有256.38万股浮盈赚取299.96万元

Group 1 - The core point of the article highlights the recent performance of Fuyuan Pharmaceutical, which saw a 5.36% increase in stock price, reaching 22.98 yuan per share, with a trading volume of 100 million yuan and a turnover rate of 0.93%, resulting in a total market capitalization of 11.03 billion yuan [1] - Fuyuan Pharmaceutical, established on February 3, 1999, and listed on June 30, 2022, is primarily engaged in the research, production, and sales of pharmaceutical preparations and medical devices, with 94.09% of its revenue coming from pharmaceutical preparations and 6.00% from medical devices [1] Group 2 - Among the top ten circulating shareholders of Fuyuan Pharmaceutical, E Fund's healthcare mixed fund A (110023) entered the list in the third quarter, holding 2.5638 million shares, which accounts for 0.53% of the circulating shares, with an estimated floating profit of approximately 2.9996 million yuan [2] - E Fund's healthcare mixed fund A (110023), established on January 28, 2011, has a latest scale of 3.802 billion yuan, with a year-to-date return of 31.25%, ranking 3013 out of 8154 in its category, and a one-year return of 22.68%, ranking 3972 out of 8046 [2] - The fund manager, Yang Zhenshao, has been in the position for 9 years and 75 days, managing a total fund asset size of 9.816 billion yuan, with the best fund return during his tenure being 209.89% and the worst being -14.74% [2]